SIP
Click for more information
1.55% $1.31 sigma pharmaceuticals limited

News: SIP Sigma Pharmaceuticals says FY underlying NPAT up 13.0 pct to $66.9 mln

  1. Hot News
    190,079 Posts.
    lightbulb Created with Sketch. 2787
    clock Created with Sketch.
    23/03/17
    08:40
    Post #: 23561580

    March 23 (Reuters) - Sigma Pharmaceuticals Ltd (SIP) :

    • FY underlying npat up 13.0% to $66.9 million
    • "we confirm our previous guidance of at least 5pct underlying ebit growth for fy18"
    • FY revenue $4.4 billion, up 26.2pct
    • Proposed final dividend of 3.0 cents per share
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SIP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.